Vertex Pharmaceuticals, Inc. (VRTX)
523.93
-11.24
(-2.10%)
USD |
NASDAQ |
Oct 23, 16:00
524.09
+0.16
(+0.03%)
After-Hours: 20:00
Vertex Pharmaceuticals Price to Book Value : 6.556 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 6.556 |
| October 22, 2026 | 6.696 |
| October 21, 2026 | 6.563 |
| October 20, 2026 | 6.440 |
| October 19, 2026 | 6.280 |
| October 16, 2026 | 6.253 |
| October 15, 2026 | 6.366 |
| October 14, 2026 | 6.237 |
| October 13, 2026 | 6.071 |
| October 12, 2026 | 6.344 |
| October 09, 2026 | 6.382 |
| October 08, 2026 | 6.297 |
| October 07, 2026 | 6.327 |
| October 06, 2026 | 6.285 |
| October 05, 2026 | 6.300 |
| October 02, 2026 | 6.315 |
| October 01, 2026 | 6.340 |
| September 30, 2026 | 6.542 |
| September 29, 2026 | 6.591 |
| September 28, 2026 | 6.602 |
| September 25, 2026 | 6.584 |
| September 24, 2026 | 6.536 |
| September 23, 2026 | 6.461 |
| September 22, 2026 | 6.444 |
| September 21, 2026 | 6.390 |
| Date | Value |
|---|---|
| September 18, 2026 | 6.360 |
| September 17, 2026 | 6.461 |
| September 16, 2026 | 6.422 |
| September 15, 2026 | 6.439 |
| September 14, 2026 | 6.500 |
| September 11, 2026 | 6.449 |
| September 10, 2026 | 6.438 |
| September 09, 2026 | 6.520 |
| September 08, 2026 | 6.618 |
| September 04, 2026 | 6.833 |
| September 03, 2026 | 6.981 |
| September 02, 2026 | 6.966 |
| September 01, 2026 | 6.852 |
| August 31, 2026 | 6.813 |
| August 28, 2026 | 6.778 |
| August 27, 2026 | 6.851 |
| August 26, 2026 | 6.848 |
| August 25, 2026 | 6.917 |
| August 24, 2026 | 6.852 |
| August 21, 2026 | 6.857 |
| August 20, 2026 | 6.760 |
| August 19, 2026 | 6.908 |
| August 18, 2026 | 6.609 |
| August 17, 2026 | 6.451 |
| August 14, 2026 | 6.328 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 16.37 |
| Sionna Therapeutics, Inc. | 0.6118 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Regeneron Pharmaceuticals, Inc. | 2.625 |
| Amgen, Inc. | 20.32 |
Price to Book Value Related Metrics
| PE Ratio | 30.48 |
| PS Ratio | 10.57 |
| PEG Ratio | 1.333 |
| Price to Free Cash Flow | 35.37 |
| Price | 523.93 |
| Earnings Yield | 3.28% |
| Market Cap | 132.74B |
| PEGY Ratio | 1.333 |
| Operating PE Ratio | 26.74 |
| Normalized PE Ratio | 29.67 |